Sona Nanotech

This week Moderna and Merck announced significant clinical study results that support a strategy of immune priming to expand the effectiveness of immunotherapy checkpoint inhibitors, as is also being developed by Sona with its THT immune modulating therap

HALIFAX, NS, Aug. 10, 2026 /CNW/ - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it … The post Sona Nanotech Closes Over-Subscribed Private Placement Financing to Raise $2,527,012 in Gross Proceeds app

Halifax, Nova Scotia - (Newsfile Corp. - July 31, 2026) - Sona Nanotech Inc. (CSE: SONA, OTCQB: SNANF) (the "Company", "Sona") announces … The post Sona Nanotech To Arrange Private Placement Financing appeared first on Sona Nanotech.

Halifax, Nova Scotia - (Newsfile Corp. - June 11, 2026) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") … The post Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors appeared fi

The first-in-human study showed THT can safely prime and shrink tumours in immunotherapy-resistant melanoma patients. The next question is what happens when … The post Investor Webinar Update May 7th 2026 appeared first on Sona Nanotech.

Halifax, Nova Scotia - (Newsfile Corp. - May 5, 2026) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is … The post Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma appeared first on

HALIFAX, NS, April 27, 2026 /CNW/ - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that its Chief Medical Officer, Dr. … The post Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences a

HALIFAX, NS, April 16, 2026 /CNW/ - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is honoured to announce the appointment of two renowned … The post Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific A

Halifax, Nova Scotia - (Newsfile Corp. - April 13, 2026) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is … The post Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy

Halifax, Nova Scotia - (Newsfile Corp. - April 7, 2026) - Sona Nanotech Inc. (CSE: SONA, OTCQB: SNANF) (the "Company", "Sona") is … The post Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy I